Disposable Bioreactor Sales

Disposable Bioreactor Sales Market Outlook

The global disposable bioreactor market is projected to reach approximately USD 5.4 billion by the year 2035, growing at a CAGR of around 15.2% during the forecast period from 2025 to 2035. This substantial growth is primarily attributed to the increasing demand for biologics, the rising number of biopharmaceuticals in development, and the need for cost-effective and flexible manufacturing solutions in the biotechnology sector. Furthermore, the shift from traditional bioreactor systems to single-use technologies is being driven by the growing focus on reducing cross-contamination risks, enhancing operational efficiency, and minimizing cleaning processes. The surge in biopharmaceutical production and advancements in cell culture technologies are also key factors that are expected to propel the growth of the disposable bioreactor market in the coming years.

Growth Factor of the Market

The growth of the disposable bioreactor market is significantly influenced by various factors that enhance its adoption across multiple sectors. One of the primary growth drivers is the increasing investment in biopharmaceutical research and development, leading to a higher demand for efficient production systems. Additionally, the introduction of advanced technologies and innovative manufacturing processes plays a crucial role in reducing production times and overall costs, thereby attracting more biopharmaceutical companies to adopt disposable bioreactor systems. The ongoing trend towards personalized medicine and the production of monoclonal antibodies necessitate scalable and flexible manufacturing solutions that disposable bioreactors can readily provide. Furthermore, regulatory support for single-use technologies, coupled with the growing awareness of sustainability and environmental concerns, is expected to contribute significantly to market growth. Together, these factors create a robust framework for the continued expansion of the disposable bioreactor market.

Key Highlights of the Market

• The market is anticipated to expand at a CAGR of 15.2% from 2025 to 2035.
• Stirred-tank single-use bioreactors are the most widely adopted product type.
• North America holds the largest market share, driven by technological advancements and research investments.
• Biopharmaceutical companies are the primary end-users, emphasizing the importance of disposable bioreactors in drug development.
• Asia Pacific is experiencing rapid growth due to increasing biopharmaceutical production and investments in biotechnology.

By Product Type

Stirred-tank Single-use Bioreactors:

Stirred-tank single-use bioreactors are among the most popular types within the disposable bioreactor segment, primarily due to their ability to provide controlled environment settings for cell culture. These bioreactors utilize a mechanical stirrer to mix the cell culture medium, ensuring optimal gas exchange and nutrient uptake for the cells. The ease of use, reduced risk of cross-contamination, and minimal cleaning requirements make stirred-tank systems highly desirable for biopharmaceutical manufacturing processes. Moreover, advancements in design and technology have enhanced their scalability, allowing for efficient production at various capacities. This versatility has led to a significant increase in their adoption in both research and commercial settings, contributing to their prominent market share.

Wave-induced Single-use Bioreactors:

Wave-induced single-use bioreactors represent an innovative approach to cell culture, utilizing wave motion to promote mixing and aeration. This method eliminates the need for mechanical stirring, which reduces shear stress on cells and increases cell viability. Wave-induced systems are particularly advantageous for sensitive cell lines, making them ideal for applications in biopharmaceuticals and regenerative medicine. As the demand for gentler processing techniques in cell culture continues to grow, wave-induced bioreactors are likely to gain traction. Their compact design and ability to integrate easily into existing workflows further enhance their appeal, positioning them as a notable segment within the disposable bioreactor market.

Bubble Column Single-use Bioreactors:

Bubble column single-use bioreactors are utilized in various applications, particularly for growing suspended cell cultures. These bioreactors operate by introducing air or gas bubbles into the culture medium, promoting mixing and oxygen transfer. Their design allows for high mass transfer rates, which is crucial for maintaining optimal cell growth conditions. The simplicity of bubble column systems, combined with their ability to operate at large scales, makes them a viable option for many biopharmaceutical manufacturers focusing on scalability and efficiency. As the industry shifts towards single-use technologies, bubble column bioreactors are positioned to provide a cost-effective solution for large-scale production needs.

Hollow Fiber Single-use Bioreactors:

Hollow fiber single-use bioreactors are gaining popularity due to their unique design that promotes efficient mass transfer and high cell density cultures. These bioreactors consist of hollow fiber membranes that facilitate nutrient exchange between the culture medium and the cells, allowing for effective waste removal and nutrient delivery. This bioreactor type is particularly well-suited for applications requiring high cell yield, such as monoclonal antibody production. The ability to achieve higher productivity with reduced culture volumes makes hollow fiber bioreactors an attractive choice for biopharmaceutical companies seeking to enhance their production processes. As a result, this segment is expected to witness substantial growth in the coming years.

Other Single-use Bioreactors:

This category encompasses various other types of disposable bioreactors that cater to specific niche applications or emerging technologies. These bioreactors can include innovative designs that utilize novel mixing technologies or specific configurations tailored to unique cell lines or production processes. The flexibility of single-use systems allows for rapid scaling and adaptation to different bioprocessing needs, making them a relevant choice for companies engaged in cutting-edge research and development. As the biopharmaceutical industry continues to evolve, the demand for diverse bioreactor options will likely grow, supporting the expansion of this segment within the market.

By Application

Biopharmaceutical Companies:

Biopharmaceutical companies are at the forefront of the disposable bioreactor market, driving significant demand for single-use technologies. These companies focus on the development and production of biologics, including proteins, antibodies, and vaccines, which require sophisticated and scalable manufacturing processes. Disposable bioreactors facilitate the rapid production of these complex products while minimizing contamination risks. Their ability to streamline operations and reduce costs associated with cleaning and sterilization makes them an attractive option for biopharmaceutical manufacturers seeking efficiency and flexibility. As the biopharmaceutical sector continues to expand, the reliance on disposable bioreactor systems is expected to increase correspondingly.

Research and Development Institutes:

Research and development institutes play a crucial role in advancing biotechnological innovations, and disposable bioreactors are essential tools within their laboratories. These institutions utilize single-use systems for experimental work, allowing researchers to conduct studies on cell behavior, drug interactions, and bioprocess optimization without the complications of cleaning and maintaining traditional bioreactor systems. The ease of use and rapid setup of disposable bioreactors enable R&D teams to focus on experimentation rather than operational logistics. As the pace of biotechnological advancements accelerates, the demand for disposable bioreactors among research institutes is likely to grow, supporting their ongoing innovation efforts.

Contract Research Organizations (CROs):

Contract Research Organizations (CROs) are increasingly turning to disposable bioreactors to meet the diverse needs of their clients in the biopharmaceutical sector. As service providers, CROs require flexible and scalable solutions to conduct various bioprocessing tasks, including preclinical and clinical production of biologics. Disposable bioreactors align with the operational goals of CROs by allowing for efficient project turnaround times and minimizing the risk of cross-contamination across different client projects. The growing trend of outsourcing research and production activities to CROs is expected to further drive the adoption of disposable bioreactor systems within this segment, as they provide the necessary adaptability and responsiveness to client demands.

Others:

This category includes various other applications where disposable bioreactors may be utilized, such as in academic institutions, governmental research labs, and smaller biotech firms. These organizations often require flexible and efficient bioprocessing solutions that can adapt to a range of experimental needs and production scales. The affordability and ease of use associated with disposable bioreactors make them suitable for these smaller players, who may not have the resources to invest in large, traditional bioreactor systems. As the biotechnology landscape continues to diversify, the potential applications for disposable bioreactors are expanding, opening new opportunities for market growth.

By User

Pharmaceutical and Biotechnology Companies:

Pharmaceutical and biotechnology companies represent the largest user segment for disposable bioreactors, as they focus primarily on the development and manufacturing of therapeutic products. These organizations require reliable and efficient bioprocessing solutions to produce high-quality biologics at scale, which disposable bioreactors readily provide. The ability to minimize cross-contamination risks and streamline production processes enhances their attractiveness to these companies. Furthermore, the increasing complexity of biologics necessitates sophisticated production systems that can accommodate varying cell lines and growth conditions, solidifying the role of disposable bioreactors as essential tools in the biopharmaceutical sector.

Contract Research Organizations (CROs):

Contract Research Organizations (CROs) are another critical user segment for disposable bioreactors, as they provide a wide range of services to pharmaceutical and biotechnology companies. CROs leverage disposable bioreactor technology to conduct clinical and preclinical studies, ensuring efficient and flexible production capabilities. These organizations often work with multiple clients, requiring systems that can be easily adjusted for different projects without the need for extensive cleaning or sterilization. The demand for CRO services is on the rise, driven by the increasing reliance of biopharmaceutical companies on outsourcing, which consequently boosts the adoption of disposable bioreactor systems in this segment.

R&D Departments:

Research and development (R&D) departments within biotechnology and pharmaceutical companies rely on disposable bioreactors for experimental work and process development. These departments often engage in the exploration of new therapeutic agents and the optimization of existing processes, necessitating flexible and efficient bioprocessing solutions. Disposable bioreactors allow R&D teams to conduct experiments without the complications associated with traditional systems, enabling rapid iteration and innovation. The emphasis on accelerating drug development timelines is likely to continue driving the demand for disposable bioreactor technologies within R&D settings.

By Type of Cell Culture

Mammalian Cell Culture:

Mammalian cell culture is one of the most prevalent applications for disposable bioreactors, particularly in the production of monoclonal antibodies and recombinant proteins. These cell cultures require specific growth conditions and nutrient media to ensure optimal cell growth and productivity. Disposable bioreactors facilitate these processes by providing controlled environments that minimize contamination risks and enhance process efficiency. The flexibility and scalability offered by single-use systems make them ideal for mammalian cell culture applications, leading to increased adoption in both research and production settings. As the demand for biologics continues to rise, the use of disposable bioreactors for mammalian cell culture will likely experience significant growth.

Bacterial Cell Culture:

Bacterial cell culture is commonly used in various biotechnological applications, including the production of vaccines, enzymes, and recombinant proteins. Disposable bioreactors designed for bacterial cultures allow for efficient growth and fermentation processes, enabling rapid production cycles and high yields. These bioreactors are particularly advantageous due to their ease of use and reduced cleaning requirements, which are essential for maintaining productivity in commercial settings. As biopharmaceutical companies continue to explore new bacterial strains and production techniques, the demand for disposable bioreactors in this segment is expected to expand accordingly.

Yeast Cell Culture:

Yeast cell culture is another essential application of disposable bioreactors, particularly in the production of biofuels, food additives, and pharmaceuticals. Yeast cultures have unique requirements regarding nutrient media and environmental conditions, making specialized bioreactor systems necessary for optimal growth and productivity. Disposable bioreactors equipped with features tailored to yeast cultures enable efficient fermentation processes while minimizing contamination risks. The growing interest in sustainable practices and bioprocessing technologies further supports the expansion of disposable bioreactors within yeast cell culture applications.

Other Cell Cultures:

This category encompasses various other cell culture types, including insect and plant cell cultures, which may utilize disposable bioreactors for specific applications. These cell cultures often require specialized conditions and nutrient media, necessitating the development of tailored bioreactor systems. The versatility of disposable bioreactors allows researchers and manufacturers to explore a range of cell culture options, fostering innovation in biotechnological applications. As the biotechnology landscape continues to evolve, the potential for the use of disposable bioreactors across diverse cell cultures will likely grow, driving further market expansion.

By Region

The disposable bioreactor market exhibits significant regional variations, driven by factors such as technological advancements, investment in biotechnology, and regulatory environments. North America currently dominates the global market, accounting for approximately 40% of the total market share. The region's robust biopharmaceutical sector and extensive research infrastructure contribute to its leading position, with the market projected to grow at a CAGR of around 14.8%. In particular, the United States is home to numerous leading biopharmaceutical companies and research institutes, driving the demand for disposable bioreactor technologies.

Europe is the second-largest market for disposable bioreactors, holding around 30% of the share. The region's emphasis on research and innovation in biotechnology, coupled with a favorable regulatory environment, supports the growth of this market. Countries such as Germany, France, and the United Kingdom are key players in the European market, contributing to advancements in biotechnological applications. The Asia Pacific region is also experiencing rapid growth, with an anticipated CAGR of 16.5% as investments in biotechnology and biopharmaceutical production facilities continue to rise in countries like China, India, and Japan. The increasing demand for biologics and advancements in manufacturing processes will further boost the disposable bioreactor market in this region.

Opportunities

The disposable bioreactor market presents numerous opportunities for growth, particularly as biopharmaceutical companies continue to transition towards single-use technologies. The increasing complexity of biologics and the demand for personalized medicine create a need for flexible and scalable manufacturing solutions that disposable bioreactors can provide. Additionally, the growing trend towards outsourcing production activities to Contract Research Organizations (CROs) offers significant potential for disposable bioreactor adoption, as these organizations require efficient systems that can adapt to a variety of projects without the burdens of extensive cleaning and sterilization. Furthermore, the rising emphasis on sustainability within the biotechnology sector is driving interest in disposable systems, as they minimize waste and reduce the environmental impact of production processes.

Another area of opportunity lies in the development of innovative disposable bioreactor designs and technologies. As research and development in the field of biotechnology continue to advance, there is potential for the introduction of new and improved bioreactor systems that enhance performance and efficiency. For example, advancements in sensor technology and process monitoring can lead to more robust and reliable bioprocessing solutions, providing manufacturers with greater control over their production processes. Additionally, expanding into emerging markets presents a significant opportunity for market players, as the rising demand for biopharmaceuticals and biotechnology services in regions such as Asia Pacific and Latin America drives the need for modern production technologies.

Threats

Despite the promising growth prospects for the disposable bioreactor market, several threats could pose challenges to its expansion. One of the primary threats is the potential for regulatory hurdles and compliance issues associated with single-use systems. As biopharmaceutical companies are subject to rigorous regulatory standards, any changes or uncertainties in the regulatory landscape could impact the adoption and utilization of disposable bioreactors. Furthermore, the market is highly competitive, with numerous players vying for market share. This competitive environment may lead to price wars, which could ultimately affect profitability for manufacturers and service providers alike. Additionally, the potential for technological advancements in traditional bioreactor systems may challenge the growth of disposable technologies, as companies explore ways to improve the efficiency and cost-effectiveness of existing systems.

Another significant threat comes from supply chain disruptions, which have been highlighted by recent global events. The reliance on single-use components sourced from various suppliers means that any disruptions in the supply chain could impact the availability and production of disposable bioreactors. Such disruptions could lead to delays in biopharmaceutical production timelines, affecting the overall market dynamics. Additionally, the increasing scrutiny regarding the environmental impact of single-use plastics poses a challenge to the sustainability of disposable bioreactor technologies. As the biotechnology industry increasingly prioritizes sustainability initiatives, the pressure to develop eco-friendly alternatives may necessitate significant changes in the production and use of disposable bioreactors.

Competitor Outlook

• Sartorius AG
• Eppendorf AG
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Pall Corporation
• Merck KGaA
• Fujifilm Diosynth Biotechnologies
• Repligen Corporation
• Lonza Group Ltd.
• Cytiva
• ABEC, Inc.
• KUBOTA Corporation
• Wuxi Apptec
• HollisterStier LLC
• Corning Incorporated

The competitive landscape of the disposable bioreactor market is characterized by a mix of established players and emerging companies, all vying for market share in a rapidly growing industry. Major players such as Sartorius AG, Thermo Fisher Scientific, and Merck KGaA dominate the landscape with their extensive product portfolios, technological innovations, and strong market presence. These companies leverage their expertise in bioprocessing technologies to develop advanced solutions that meet the evolving needs of biopharmaceutical manufacturers and research institutions. Additionally, the focus on strategic collaborations, partnerships, and acquisitions enables these companies to enhance their product offerings and expand their market reach.

Emerging companies and startups also play a crucial role in the disposable bioreactor market, often focusing on niche applications or innovative technologies that address specific challenges faced by biopharmaceutical manufacturers. These companies are increasingly contributing to the diversity of product offerings available in the market, fostering healthy competition and stimulating innovation. The presence of a wide range of product options ensures that customers can find tailored solutions to suit their unique bioprocessing requirements. As the industry continues to evolve, the competitive landscape will likely see changes, with new entrants and innovations reshaping the market dynamics.

In terms of major companies, Sartorius AG stands out as a leader in the disposable bioreactor market, offering a comprehensive range of single-use systems designed for various biopharmaceutical applications. The company’s commitment to innovation and quality has positioned it as a trusted partner for manufacturers seeking reliable bioprocessing solutions. Similarly, Thermo Fisher Scientific is renowned for its extensive portfolio of bioprocessing products, including disposable bioreactor technologies that cater to different production scales and cell culture types. Merck KGaA, with its strong emphasis on research and development, continues to introduce next-generation bioreactor systems that enhance productivity and efficiency for biopharmaceutical companies.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cytiva
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 ABEC, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Wuxi Apptec
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Eppendorf AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Sartorius AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 GE Healthcare
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Lonza Group Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Pall Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 HollisterStier LLC
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 KUBOTA Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Corning Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Repligen Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fujifilm Diosynth Biotechnologies
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Disposable Bioreactor Sales Market, By user
    • 6.1.1 Pharmaceutical and Biotechnology Companies
    • 6.1.2 CROs
    • 6.1.3 R&D Departments
  • 6.2 Disposable Bioreactor Sales Market, By Application
    • 6.2.1 Biopharmaceutical Companies
    • 6.2.2 Research and Development Institutes
    • 6.2.3 Contract Research Organizations
    • 6.2.4 Others
  • 6.3 Disposable Bioreactor Sales Market, By Product Type
    • 6.3.1 Stirred-tank Single-use Bioreactors
    • 6.3.2 Wave-induced Single-use Bioreactors
    • 6.3.3 Bubble Column Single-use Bioreactors
    • 6.3.4 Hollow Fiber Single-use Bioreactors
    • 6.3.5 Other Single-use Bioreactors
  • 6.4 Disposable Bioreactor Sales Market, By Type of Cell Culture
    • 6.4.1 Mammalian Cell Culture
    • 6.4.2 Bacterial Cell Culture
    • 6.4.3 Yeast Cell Culture
    • 6.4.4 Other Cell Cultures

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Disposable Bioreactor Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Disposable Bioreactor Sales market is categorized based on

By Product Type

• Stirred-tank Single-use Bioreactors
• Wave-induced Single-use Bioreactors
• Bubble Column Single-use Bioreactors
• Hollow Fiber Single-use Bioreactors
• Other Single-use Bioreactors

By Application

• Biopharmaceutical Companies
• Research and Development Institutes
• Contract Research Organizations
• Others

By user

• Pharmaceutical and Biotechnology Companies
• CROs
• R&D Departments

By Type of Cell Culture

• Mammalian Cell Culture
• Bacterial Cell Culture
• Yeast Cell Culture
• Other Cell Cultures

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Sartorius AG
• Eppendorf AG
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Pall Corporation
• Merck KGaA
• Fujifilm Diosynth Biotechnologies
• Repligen Corporation
• Lonza Group Ltd.
• Cytiva
• ABEC, Inc.
• KUBOTA Corporation
• Wuxi Apptec
• HollisterStier LLC
• Corning Incorporated